Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 12Completed 9Unknown 6Not yet recruiting 5Terminated 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 7Gastrointestinal 6Other hematologic neoplasm 5Thoracic 4Breast 4Genitourinary 3Tumor-Agnostic 2Myeloid 2Gynecologic 2Lymphoid 1Dermatologic 1CNS 1

Conditions

Uterine Cervical Neoplasms 1Pelvic Neoplasms 1Hypoxia 1

Interventions

Paclitaxel 69Carboplatin 66Cisplatin 36pembrolizumab 34Gemcitabine 24liposomal doxorubicin 23Cyclophosphamide 23Topotecan 22Bevacizumab 20Taxes 14Docetaxel 13niraparib 12Nivolumab 12olaparib 10fludarabine 10Doxorubicin 9Surveys and Questionnaires 8Radiotherapy 8Oxaliplatin 8aldesleukin 7Filgrastim 7rucaparib 6oregovomab 6fludarabine phosphate 6durvalumab 6avelumab 6Interleukin-2 6Hyperthermic Intraperitoneal Chemotherapy 6Fluorodeoxyglucose F18 6Cytoreduction Surgical Procedures 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Injections × Gynecologic × Clear all
NCT04199754 2024-05-31

IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy

Columbia University

Phase EARLY_PHASE1 Terminated
6 enrolled
Gynecologic

Pelvic Neoplasms

NCT02233387 2019-03-08

HX4-cervix

Maastricht Radiation Oncology

Phase 2 Terminated
4 enrolled
Gynecologic

Hypoxia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡